Tepezza hearing loss litigation — safety… | DrugsMonitor.com

Clinical summary and reported injury patterns for Tepezza hearing loss litigation. Links to FDA recalls and litigation overview. Not medical advice.

teprotumumab, thyroid eye disease, tinnitus, sensorineural hearing loss

Clinical context

Teprotumumab for thyroid eye disease is alleged to cause permanent hearing loss and tinnitus in some patients.

Litigation context

MDL No. 3079 in the Northern District of Illinois; discovery ongoing.